Understanding Your Cancer at the Genetic Level
When you’re facing a cancer diagnosis, every piece of information matters. The KRAS NRAS Mutation Analysis Panel goes beyond standard cancer testing to examine the specific genetic mutations driving your cancer’s growth. This isn’t just another test – it’s a roadmap that helps your oncologist choose the most effective treatment strategy specifically for you.
What This Test Reveals About Your Cancer
This advanced genetic panel specifically analyses mutations in the KRAS and NRAS genes, which play crucial roles in cell growth and division. When these genes develop mutations, they can drive cancer progression and affect how your cancer responds to certain targeted therapies. By identifying these specific mutations, we provide your healthcare team with actionable information that can significantly impact your treatment outcomes.
Who Should Consider This Genetic Analysis?
This test is particularly important for patients diagnosed with:
- Colorectal cancer
- Non-small cell lung cancer
- Pancreatic cancer
- Other solid tumours where KRAS/NRAS status guides treatment
If you’re about to start targeted therapy or your current treatment isn’t delivering the expected results, this genetic analysis could provide the clarity needed to adjust your treatment plan effectively.
Why Genetic Testing Matters for Your Treatment Journey
Understanding your cancer’s genetic profile offers several critical benefits:
- Personalised Treatment Selection: Avoid treatments that won’t work and focus on those more likely to be effective
- Reduced Treatment Side Effects: By choosing targeted therapies, you may experience fewer unnecessary side effects
- Improved Treatment Outcomes: Targeted approaches based on genetic information often lead to better responses
- Peace of Mind: Knowing you’re pursuing the most appropriate treatment path for your specific cancer
Understanding Your Test Results
Your results will clearly indicate whether KRAS or NRAS mutations are present in your cancer cells. A positive result means mutations were detected, which helps your oncologist determine which targeted therapies might be most effective. A negative result indicates no detectable mutations, which also provides valuable information for treatment planning. Our genetic counsellors and medical team are available to help you understand what your results mean for your specific situation.
Transparent Pricing for Peace of Mind
| Test | Regular Price | Special Price |
|---|---|---|
| KRAS NRAS Mutation Analysis Panel | R8,350 | R5,000 |
This investment in precise genetic information could save you from costly, ineffective treatments and help guide you toward the most appropriate therapy for your cancer.
Nationwide Access Across South Africa
We provide comprehensive testing services throughout South Africa, with convenient sample collection available in Johannesburg, Cape Town, Durban, Pretoria, and surrounding areas. Our network ensures that quality genetic testing is accessible when and where you need it most.
Take Control of Your Cancer Treatment Today
Don’t leave your treatment decisions to chance. The KRAS NRAS Mutation Analysis Panel provides the genetic clarity needed to make informed decisions about your cancer care. With results typically available within our standard turnaround time, you can quickly move forward with confidence in your treatment plan.
Ready to get the genetic information that could transform your cancer treatment? Contact Oracle Genomics today to schedule your test or speak with our genetic counselling team about whether this analysis is right for your situation.
Trust Oracle Genomics for accurate, reliable genetic testing that puts your health journey first.
